| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 08/20/2003 | CN1437581A Glucagon antagonists/inverse agonists |
| 08/20/2003 | CN1437074A Electrophotographical photoreceptor and electronic photographic equipment using the same photoreceptor |
| 08/20/2003 | CN1436778A Quino-methane compound |
| 08/20/2003 | CN1118476C Antiviral protease inhibitors |
| 08/19/2003 | US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 08/19/2003 | US6608101 1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders |
| 08/19/2003 | US6608100 HIV protease inhibitors based on amino acid derivatives |
| 08/19/2003 | US6608090 Post-menopausal osteoporosis, hyperlipidemia, and estrogen dependent cancer, particularly breast and uterine cancer; 2-phenylbenzo(B)thiophene 3-substituted with a 4-aminoethoxy benzoyl group, the amino in piperidine or pyrrolidine ring |
| 08/19/2003 | US6608066 Tissue factor antagonists and methods of use thereof |
| 08/19/2003 | CA2043733C Aromatic compounds |
| 08/14/2003 | WO2003067332A2 Sulfonate derivatives and the use therof as latent acids |
| 08/14/2003 | WO2003066889A2 Assay for acytyltransferase or deacetylase activity |
| 08/14/2003 | WO2003066583A1 Astaxanthin esters |
| 08/14/2003 | WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 08/14/2003 | WO2003066056A1 Method of promoting neuronal growth |
| 08/14/2003 | WO2003066035A2 Compounds for inhibiting insulin secretion and methods related thereto |
| 08/14/2003 | WO2003065789A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 08/14/2003 | WO2003024955A3 Small molecule inhibitors of caspases |
| 08/14/2003 | US20030153602 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
| 08/14/2003 | US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 08/14/2003 | US20030153577 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 08/14/2003 | US20030153557 Treating osteoporosis, cardiovascular disorders, restenosis, arteriosclerosis, nephropathies or retinopathies; antitumor and antiinflammatory agents |
| 08/14/2003 | CA2474532A1 Sulfonate derivatives and the use therof as latent acids |
| 08/14/2003 | CA2473778A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 08/14/2003 | CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 08/13/2003 | EP1335250A1 Electrophotographic organophotoreceptors with novel charge transport materials |
| 08/13/2003 | EP1334961A1 Process for the preparation of glycine-N,N-diacetic acid derivatives |
| 08/13/2003 | EP1334956A2 Method for preparing sulfone or sulfoxide compound |
| 08/13/2003 | EP1334095A1 Process for the preparation of pgd2 antagonist |
| 08/13/2003 | EP1334094A1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles |
| 08/13/2003 | EP1334085A1 Sulfamides as gamma-secretase inhibitors |
| 08/13/2003 | EP1256340B1 Improved transdermal therapeutic system for the treatment of Parkinson's disease |
| 08/13/2003 | EP1222166B1 Novel p-aminophenols and colorants containing said compounds |
| 08/13/2003 | EP1216244B1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists |
| 08/13/2003 | EP0946539B1 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
| 08/13/2003 | CN1436168A Beta-amino acid nitrile derivs. |
| 08/13/2003 | CN1117743C Process for producing 5-hydroxybenzoÒÇöbÒÇò thiophene-3-carboxylic acid derivs. |
| 08/13/2003 | CN1117727C Process for hydrogenation of imines |
| 08/12/2003 | US6605730 3-(2-Thienyl)-5-phenyl-1H-pyrazole compounds of given formula |
| 08/12/2003 | US6605632 Affinity for melatonin receptors |
| 08/12/2003 | US6605626 Antithrombotic agents |
| 08/12/2003 | US6605615 Administering to a patient suffering from hypercholesterolemia, hyperlipedimea and other metabolic disorders an effective amount of hydrozone, oxime or imine derivatives |
| 08/07/2003 | WO2003064376A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps) |
| 08/07/2003 | WO2003064373A1 Triarylamine derivatives and the use thereof in organic electroluminescent and electrophotographic devices |
| 08/07/2003 | WO2003064372A1 2-adamantylalkylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
| 08/07/2003 | WO2003063797A2 Cycloalkyl inhibitors of potassium channel function |
| 08/07/2003 | WO2003063576A2 Arylsulfonamidobenzylic compounds |
| 08/07/2003 | US20030149250 Labeled compounds useful in imaging amyloid deposits and useful for inhibiting the aggregation of amyloid protein to form amyloid deposit |
| 08/07/2003 | US20030149107 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 08/07/2003 | US20030149052 Side effect reduction |
| 08/07/2003 | US20030149030 7-phenyl-benzo [b] thiophen amide derivatives |
| 08/07/2003 | US20030149023 Novel compounds with analgesic effect |
| 08/07/2003 | US20030149015 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives |
| 08/07/2003 | US20030149006 New vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents |
| 08/07/2003 | US20030148890 Organic compounds |
| 08/07/2003 | US20030148877 Metallocenes and catalysts for olefin-polymerisation |
| 08/07/2003 | CA2474451A1 Cycloalkyl inhibitors of potassium channel function |
| 08/07/2003 | CA2474433A1 Arylsulfonamidobenzylic compounds |
| 08/06/2003 | EP1332131A2 Acid derivatives useful as serine protease inhibitors |
| 08/06/2003 | EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 08/06/2003 | EP1189929B1 Factor viia inhibitors |
| 08/06/2003 | EP1049537B1 Catalytic compositions and methods for asymmetric allylic alkylation |
| 08/06/2003 | EP0934321B1 Thienopyrimidine with phosphodiesterase v inhibiting effect |
| 08/06/2003 | EP0918747B1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF |
| 08/06/2003 | EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 08/06/2003 | CN1117081C Inhibition of raf kinase using aryl and hetroaryl substituted heterocyclic ureas |
| 08/06/2003 | CN1117074C Benzamidoxim derivatives, intermediate productsand method for preparing and using as fungicides |
| 08/06/2003 | CN1117071C Pesticides |
| 08/05/2003 | US6603044 Phthalamide derivatives, or salt thereof agrohorticultural insecticide, and method for using the same |
| 08/05/2003 | US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents |
| 08/05/2003 | US6603012 RAR selective retinoid agonists |
| 08/05/2003 | US6602874 5-(2-(4-methylpiperazin-1-yl)-phenyl)- furan-2-carboxylic acid 4-chlorobenzylamide, for example; treating or preventing migraine, depression and other disorders for which a 5-HT1, agonist or antagonist is indicated |
| 08/05/2003 | US6602647 Sulfonium salt compound and resist composition and pattern forming method using the same |
| 08/05/2003 | CA2275827C Method for treating glaucoma |
| 07/31/2003 | WO2003062248A2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 07/31/2003 | WO2003062219A1 Process for preparing an intermediate useful for the asymmetric synthesis of duloxetine |
| 07/31/2003 | WO2003062181A1 PROCESS FOR THE PREPARATION OF NONRACEMIC SYN-1-(4-HYDROXY-PHENYL)-2-(4-HYDROXY-4-PHENYL.PIPERIDIN-1Yl)-1-PROPANOL COMPOUNDS |
| 07/31/2003 | WO2003062180A1 Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1-yl)-1-propanol compounds |
| 07/31/2003 | WO2003061826A1 Process for preparing nonracemic chiral alcohols |
| 07/31/2003 | WO2003061824A1 Process for preparing nonracemic chiral alcohols |
| 07/31/2003 | WO2003061698A1 6-fluorobicyclo[3.1.0]hexane derivatives |
| 07/31/2003 | WO2003041649A3 Cyanoalkylamino derivatives as protease inhibitors |
| 07/31/2003 | WO2003027061A3 Muscarinic agonists |
| 07/31/2003 | WO2003020677A3 C2-substituted indane-1-ones and their derivatives, method for their production and their use as medicaments |
| 07/31/2003 | WO2002094767A3 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
| 07/31/2003 | WO2002062762A3 Potassium channel openers |
| 07/31/2003 | WO2002020500A3 Materials and methods to potentiate cancer treatment |
| 07/31/2003 | US20030144531 Preparing chirally pure S-enantiomers of alpha -amino acids comprising the steps of: a) preparing an organometallic reagent from an alkyl halide of the formula (R) 2CH(CH2)nCH2X; b) adding the organometallic reagent to carbon dioxide to form |
| 07/31/2003 | US20030144526 Calcium receptor-active compounds |
| 07/31/2003 | US20030144521 Hydrogenation of a corresponding nonracemic 1-(4-benzoxy phenyl)-2-(4-hydroxy-4- phenyl-piperidin-1-yl)-1-propanone using a catalyst system comprising ruthenium, a nonracemic diphosphine ligand, a bidentate amine ligand selected from |
| 07/31/2003 | US20030144505 Novel compounds |
| 07/31/2003 | US20030144504 Dialkyl-halogenophenyl-substituted ketoenols |
| 07/31/2003 | US20030144439 Synthesis of alpha, beta, beta-trifluorostyrene via in-situ formation of trifluorovinyl metal halide |
| 07/31/2003 | US20030144343 To treat and/or prevent hypertension, cardiac hypertrophy, cardiac insufficiency, coronary heart diseases such as angina pectoris, and endothelial dysfunction or endothelial damage as a consequence of atherosclerotic processes or diabetes |
| 07/31/2003 | US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/31/2003 | US20030144310 Neuropeptide FF agonists and antagonist for G-protein coupled receptors; analgesics; urogenital disorders; drug abuse; incontinence; as an example, 2,6-Dichlorophenylsulfonylamido-Arg-Phe-NH2 |
| 07/31/2003 | US20030144265 HIV protease inhibitors based on amino acid derivatives |
| 07/31/2003 | US20030144253 Useful for treating or preventing neuronal damage associated with neurological diseases |
| 07/31/2003 | US20030144137 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation |
| 07/31/2003 | CA2471389A1 Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1yl)-1-propanol compounds |